Yayın:
In vitro evaluation of combination of EGCG and Erlotinib with classical chemotherapeutics on JAR cells

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTasa, Burcugül Altuğ
dc.contributor.authorGenç, Hatice
dc.contributor.authorKoparal, Ayşe Tansu
dc.contributor.authorSinan Özalp
dc.contributor.authorAyşe Tansu Koparal
dc.contributor.orcid0000-0002-3228-8809
dc.contributor.orcid0000-0003-4460-8467
dc.contributor.orcid0000-0001-8201-6708
dc.date.accessioned2025-11-13T10:56:01Z
dc.date.issued2017-05-01
dc.identifier.doihttps://doi.org/10.1007/s11626-017-0145-2
dc.identifier.endpage658
dc.identifier.issn1071-2690
dc.identifier.issue7
dc.identifier.openalexW2610189207
dc.identifier.startpage651
dc.identifier.urihttps://hdl.handle.net/11421/5703
dc.identifier.urihttps://doi.org/10.1007/s11626-017-0145-2
dc.identifier.volume53
dc.language.isoen
dc.relation.ispartofIn Vitro Cellular & Developmental Biology - Animal
dc.rightsrestrictedAccess
dc.subjectErlotinib
dc.subjectApoptosis
dc.subjectPharmacology
dc.subjectCancer research
dc.subjectWestern blot
dc.subjectChoriocarcinoma
dc.subjectMTT assay
dc.subjectIn vitro
dc.subjectMedicine
dc.subjectMethotrexate
dc.subjectOncology
dc.subjectChemistry
dc.subjectCancer
dc.subjectInternal medicine
dc.subjectEpidermal growth factor receptor
dc.subjectBiochemistry
dc.subject.sdg3
dc.titleIn vitro evaluation of combination of EGCG and Erlotinib with classical chemotherapeutics on JAR cells
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5031310584
local.authorid.openalexA5046468852
local.authorid.openalexA5026737372

Dosyalar

Koleksiyonlar

Publications